NCT07650097

Brief Summary

Falls are a major health problem for people over 75 years old. Backward walking may strengthen the muscles of the legs, improve posture and balance, and make walking more stable, which could help prevent new falls and improve everyday movement. This is an open-label, multicenter, randomized controlled trial that will examine whether backward walking, integrated to usual rehabilitation in a geriatric day hospital program, can help reduce the number of new falls in older adult at high risk of falling. About 300 people aged over 75 years, living at home and at high risk of falling, will be included in this trial in 11 geriatric day hospitals in France. After receiving appropriate information, those who agree to participate will sign a written consent form and will then be randomly assigned to one of two groups. Both groups will receive standard rehabilitation care in the geriatric day hospital, with two rehabilitation sessions per week for 12 weeks. In the control group, patients will only receive usual care to prevent falls previously described above. In the intervention group, part of the usual care will be replaced, for 5 weeks, by supervised backward walking exercises, with the goal of doing two effective 10 minute backward walking sessions per week, without increasing the total time spent in rehabilitation. The trial will be conducted under the intention-to-treat principle. Participants will have a clinical visit at day 0, at week 5 and at 6 months, during which clinical information and data related to their usual care and to the study will be collected. All participants will be followed for a total of 12 months, with monthly phone calls from a study team member to record any new falls, hospitalizations, health problems, or other important events. For 10 patients in the intervention group, an individual interview will also be carried out at the 5 week visit to better understand their experience of backward walking. 2 focus groups will be held with 2 randomly selected centers to identify barriers and facilitators to the implementation of backward walking sessions. This study aims to determine whether adding backward walking to standard rehabilitation is a safe, acceptable and effective way to prevent falls in older adults at high risk of falling.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for not_applicable

Timeline
30mo left

Started Sep 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 10, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 16, 2026

Completed
3 months until next milestone

Study Start

First participant enrolled

September 15, 2026

Expected
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2029

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2029

Last Updated

July 6, 2026

Status Verified

June 1, 2026

Enrollment Period

2.5 years

First QC Date

June 10, 2026

Last Update Submit

July 1, 2026

Conditions

Keywords

FallGeriatricsWalking backwards

Outcome Measures

Primary Outcomes (1)

  • Number of falls per patient between inclusion and one year of follow-up including rehabilitation period in a geriatric day hospital

    Number of falls per patient

    12 months after inclusion

Secondary Outcomes (15)

  • Balance assessment

    At inclusion, Week 5 and 6 months

  • Assessment of walking speed

    At inclusion, Week 5 and 6 months

  • Measuring fear of falling

    At inclusion, Week 5 and 6 months

  • Assessment of functional mobility

    At inclusion, Week 5 and 6 months

  • Time to first fall in days

    From inclusion to 12 months (monthly)

  • +10 more secondary outcomes

Study Arms (2)

Walking backwards

EXPERIMENTAL
Other: Walking backwards

Usual walking

ACTIVE COMPARATOR
Other: Usual walking

Interventions

Standard care combined with rehabilitation sessions involving walking backwards. Ten rehabilitation sessions involving walking backwards are scheduled, at a rate of two sessions per week for five weeks, on a secure treadmill designed for walking backwards. Walking backwards will not add to the rehabilitation time; it will replace standard care to allow for two 10-minute sessions of actual walking backwards per week. Walking backwards are integrated to the 12 weeks standard program.

Walking backwards

The standard program runs for 12 weeks, with sessions twice a week, comprising two 45-minute activities per day. At least one session per week must include balance training, muscle strengthening and multi-modal exercises. The treadmill may be used for these activities, but only for walking forwards.

Usual walking

Eligibility Criteria

Age76 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • People aged over 75
  • Consultant at a geriatric day hospital
  • At high risk of falling. High risk of falling is defined in accordance with the World guidelines for falls prevention and management for older adults: a global initiative. The patient must have at least one of the following characteristics:
  • At least two falls in the last 12 months;
  • A fall resulting in an injury requiring medical attention;
  • Inability to get up unaided after a fall for at least one hour;
  • Suspected syncope;
  • Frailty (Clinical Frailty Scale ≥4)
  • Able to walk on a treadmill (physically able and capable of understanding the physiotherapist's instructions)
  • Able to understand and follow instructions from healthcare professionals
  • Patient or guardian who has been informed about the study and has given their free, informed and written consent to participate
  • Covered by a social security scheme (member or beneficiary) excluding Aide Médicale d'Etat (AME).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital Charles-Foix

Ivry-sur-Seine, 94205, France

Location

Study Officials

  • Bruno OQUENDO, Dr

    Hôpital Charles-Foix - Assistance Publique Hôpitaux de Paris

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Bruno OQUENDO, Dr

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 10, 2026

First Posted

June 16, 2026

Study Start (Estimated)

September 15, 2026

Primary Completion (Estimated)

March 15, 2029

Study Completion (Estimated)

March 15, 2029

Last Updated

July 6, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will share

The procedures carried out with the French data privacy authority (CNIL, Commission nationale de l'informatique et des libertés) do not provide for the transmission of the database, nor do the information and consent documents signed by the patients. Consultation by the editorial board or interested researchers of individual participant data that underlie the results reported in the article after deidentification may nevertheless be considered, subject to prior determination of the terms and conditions of such consultation and in respect for compliance with the applicable regulations.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Beginning 3 months and ending 3 years following article publication. Requests out of these time frame can also be submitted to the sponsor
Access Criteria
Researchers who provide a methodologically sound proposal

Locations